BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1781 related articles for article (PubMed ID: 11687119)

  • 21. Huperzine A for Alzheimer's disease.
    Li J; Wu HM; Zhou RL; Liu GJ; Dong BR
    Cochrane Database Syst Rev; 2008 Apr; (2):CD005592. PubMed ID: 18425924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Donepezil for mild and moderate Alzheimer's disease.
    Birks J S; Melzer D
    Cochrane Database Syst Rev; 2000; (2):CD001190. PubMed ID: 10796620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rivastigmine for Alzheimer's disease.
    Birks JS; Chong LY; Grimley Evans J
    Cochrane Database Syst Rev; 2015 Sep; 9(9):CD001191. PubMed ID: 26393402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.
    Fioravanti M; Flicker L
    Cochrane Database Syst Rev; 2001; 2001(4):CD003159. PubMed ID: 11687175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WITHDRAWN: Tacrine for Alzheimer's disease.
    Qizilbash N; Birks J; Lopez Arrieta J; Lewington S; Szeto S
    Cochrane Database Syst Rev; 2007 Jul; (3):CD000202. PubMed ID: 17636619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rivastigmine for Alzheimer's disease.
    Birks J; Iakovidou V; Tsolaki M
    Cochrane Database Syst Rev; 2000; (2):CD001191. PubMed ID: 10796621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donepezil for mild and moderate Alzheimer's disease.
    Birks JS; Melzer D; Beppu H
    Cochrane Database Syst Rev; 2000; (4):CD001190. PubMed ID: 11034704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selegiline for Alzheimer's disease.
    Birks J; Flicker L
    Cochrane Database Syst Rev; 2003; (1):CD000442. PubMed ID: 12535396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of donepezil, galantamine and rivastigmine in 938 Italian patients with Alzheimer's disease: a prospective, observational study.
    Santoro A; Siviero P; Minicuci N; Bellavista E; Mishto M; Olivieri F; Marchegiani F; Chiamenti AM; Benussi L; Ghidoni R; Nacmias B; Bagnoli S; Ginestroni A; Scarpino O; Feraco E; Gianni W; Cruciani G; Paganelli R; Di Iorio A; Scognamiglio M; Grimaldi LM; Gabelli C; Sorbi S; Binetti G; Crepaldi G; Franceschi C
    CNS Drugs; 2010 Feb; 24(2):163-76. PubMed ID: 20088621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An open-label extension trial of galantamine in patients with probable vascular dementia and mixed dementia.
    Erkinjuntti T; Kurz A; Small GW; Bullock R; Lilienfeld S; Damaraju CV;
    Clin Ther; 2003 Jun; 25(6):1765-82. PubMed ID: 12860497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of a flexible galantamine dose in Alzheimer's disease: a randomised, controlled trial.
    Rockwood K; Mintzer J; Truyen L; Wessel T; Wilkinson D
    J Neurol Neurosurg Psychiatry; 2001 Nov; 71(5):589-95. PubMed ID: 11606667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydergine for dementia.
    Olin J; Schneider L; Novit A; Luczak S
    Cochrane Database Syst Rev; 2000; 2000(2):CD000359. PubMed ID: 10796534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physostigmine for Alzheimer's disease.
    Coelho F; Birks J
    Cochrane Database Syst Rev; 2001; 2001(2):CD001499. PubMed ID: 11405996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimal dosing of galantamine in patients with mild or moderate Alzheimer's disease: post Hoc analysis of a randomized, double-blind, placebo-controlled trial.
    Aronson S; Van Baelen B; Kavanagh S; Schwalen S
    Drugs Aging; 2009; 26(3):231-9. PubMed ID: 19358618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.
    Parsons C; Lim WY; Loy C; McGuinness B; Passmore P; Ward SA; Hughes C
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD009081. PubMed ID: 35608903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tacrine for Alzheimer's disease.
    Qizilbash N; Birks J; Lopez Arrieta J; Lewington S; Szeto S
    Cochrane Database Syst Rev; 2000; (3):CD000202. PubMed ID: 10908463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Memantine for dementia.
    Areosa SA; Sherriff F
    Cochrane Database Syst Rev; 2003; (1):CD003154. PubMed ID: 12535459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Memantine for dementia.
    Areosa SA; Sherriff F
    Cochrane Database Syst Rev; 2003; (3):CD003154. PubMed ID: 12917950
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 90.